FDA approval decision for Human Genome Sciences' (HGSI) lupus drug Benlysta.
Onyx Pharmaceuticals investor/analyst meeting.Dec. 16: FDA approval decision for AstraZeneca's (AZN) blood thinner Brilinta. Dec. 29: FDA approval decision for Alimera Sciences' (ALIM - Get Report) Iluvien for treatment of diabetic macular edema. FDA approval decision for MannKind's (MNKD) inhaled insuline device Afrezza --Written by Adam Feuerstein in Boston.
>To contact the writer of this article, click here: Adam Feuerstein. >To follow the writer on Twitter, go to http://twitter.com/adamfeuerstein. >To submit a news tip, send an email to: firstname.lastname@example.org.